Emerging evidence suggests that nicotinamide N-methyltransferase (NNMT), an enzyme that catalyzes the methylation of nicotinamide, may play a role in the pathophysiology of T2DM and metabolic syndrome. The gene discussed is NNMT; the disease is metabolic syndrome.